These Generic Drugs Stocks Are Standing Out

PrescriptionToday’s article highlights three generic drug stocks that you may want to check out. Here’s what they had to say about one of them, “If you’re looking for impressive numbers in a generic drug stock, look no further than Lannett. The company made nearly $274 million in revenue with over $57 million going to the bottom line last fiscal year. Lannett’s return on equity stands at 40% — a figure that would bring smiles to the faces of most investors.” To read more, CLICK HERE.